A team led by McMaster University researchers Gilmar Reis and Edward Mills has discovered that a single injection of pegylated interferon lambda (lambda) can successfully treat COVID-19 in people early in the disease.
An international award named for McMaster University’s founding father of Canadian evidence-based medicine has been brought home for the first time by a research team from the department he established.
Ivermectin, an anti-parasitic drug, has been a controversial topic for much of the COVID-19 pandemic.